Effect of rapamycin on hepatocyte function and proliferation induced by growth factors

Chemotherapy

Volumn 53, Issue 1, 2007, Pages 59-69

  Tomiya, Tomoaki ^a,c   Yamaoka, Miho ^b   Inoue, Yukiko ^a   Nishikawa, Takako ^a   Yanase, Mikio ^a   Ikeda, Hitoshi ^a   Tejima, Kazuaki ^a   Nagashima, Kayo ^a   Watanabe, Naoko ^a   Omata, Masao ^a   Fujiwara, Kenji ^b  

^a UNIVERSITY OF TOKYO   (Japan)

^b SAITAMA MEDICAL UNIVERSITY   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

Author keywords

Albumin; Fibrinogen; Hepatocyte growth factor; Rapamycin; Transforming growth factor ; Wortmannin

Indexed keywords

ALBUMIN; DNA; FIBRINOGEN; MAMMALIAN TARGET OF RAPAMYCIN; PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR; RAPAMYCIN; SCATTER FACTOR; TRANSFORMING GROWTH FACTOR ALPHA; WORTMANNIN;

ANIMAL CELL; ANIMAL CELL CULTURE; ARTICLE; CELL DENSITY; CELL FUNCTION; CELL ISOLATION; CELL LEVEL; CELL PROLIFERATION; CONTROLLED STUDY; CULTURE MEDIUM; DNA SYNTHESIS; DOSE RESPONSE; DRUG EFFECT; DRUG MECHANISM; LIVER CELL; LIVER FUNCTION; NONHUMAN; PRIORITY JOURNAL; RAT;

ALBUMINS; ANDROSTADIENES; ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; CELL PROLIFERATION; CELLS, CULTURED; CULTURE MEDIA; DNA REPLICATION; FIBRINOGEN; HEPATOCYTE GROWTH FACTOR; HEPATOCYTES; PROTEIN KINASES; RATS; SIGNAL TRANSDUCTION; SIROLIMUS; TRANSFORMING GROWTH FACTOR ALPHA;

EID: 33846435319     PISSN: 00093157     EISSN: None     Source Type: Journal    
DOI: 10.1159/000098420     Document Type: Article

References (43)

1. Vezina C, Kudelski A, Sehgal SN: Rapamycin (AY-22,989), a new antifungal antibiotic. 1. Taxonomy of the producing streptomycete and isolation of the active principle. J Antibiot 1975;28:721-726.
2. Sehgal SN, Baker H, Vezina C: Rapamycin (AY-22,989), a new antifungal antibiotic. 2. Fermentation, isolation and characterization. J Antibiot 1975;28:727-732.
3. Fingar DC, Blenis J: Target of rapamycin (TOR): an integrator of nutrient and growth factor signals and coordinator of cell growth and cell cycle progression. Oncogene 2004;23:3151-3171.
4. Rowinsky EK: Targeting the molecular target of rapamycin (mTOR). Curr Opin Oncol 2004;16:564-575.
5. Alsina J, Grinyo JM: New immunosuppressive agent: expectations and controversies. Transplantation 2003;75:741-742.
6. Chan S: Targeting the mammalian target of rapamycin (mTOR): a new approach to treating cancer. Br J Cancer 2004;91:1420-1424.
7. Stromberg T, Dimberg A, Hammarberg A, Carlson K, Osterborg A, Nilsson K, Jernberg-Wiklund H: Rapamycin sensitizes multiple myeloma cells to apoptosis induced by dexamethasone. Blood 2004;103:3138-3147.
8. Decker T, Hipp S, Ringshausen I, Bogner C, Oelsner M, Schneller F, Peschel C: Rapamycin-induced G1 arrest in cycling B-CLL cells is associated with reduced expression of cyclin D3, cyclin E, cyclin A, and survivin. Blood 2003;101:278-285.
9. Dobesh PP, Stacy ZA, Ansara AJ, Enders JM: Drug-eluting stents: a mechanical and pharmacologic approach to coronary artery disease. Pharmacotherapy 2004;24:1554-1577.
10. Beyar R: Novel approaches to reduce restenosis. Ann N Y Acad Sci 2004;1015:367-378.
11. Fausto N: Hepatic regeneration; in Zakim D, Boyer TD (eds): Hepatology. A Text Book of Liver Disease, ed 3. Philadelphia, Saunders, 1996, pp 32-58.
12. Michalopoulos GK, DeFrances MC: Liver regeneration. Science 1997;276:60-66.
13. Rajah TT, Rambo DJ, Dmytryk JJ, Pento JT: Influence of antiestrogens on NIH-3T3-fibroblast-induced motility of breast cancer cells. Chemotherapy 2001;47:56-69.
14. Milland J, Tsykin A, Thomas T, Aldred AR, Cole T, Schreiber G: Gene expression in regenerating and acute-phase rat liver. Am J Physiol 1990;259:G340-G347.
15. Panduro A, Shalaby F, Weiner FR, Biempica L, Zern MA, Shafritz DA: Transcriptional switch from albumin to alpha-fetoprotein and changes in transcription of other genes during carbon tetrachloride induced liver regeneration. Biochemistry 1986;25:1414-1420.
16. Yamaoka M, Hirata K, Ogata I, Tomiya T, Nagoshi S, Mochida S, Fujiwara K: Enhancement of albumin production by hepatocyte growth factor in rat hepatocytes: distinction in mode of action from stimulation of DNA synthesis. Liver 1998;18:52-59.
17. Takehara T, Matsumoto K, Nakamura T: Cell density-dependent regulation of albumin synthesis and DNA synthesis in rat hepatocytes by hepatocyte growth factor. J Biochem 1992;112:330-334.
18. Ishiki Y, Ohnishi H, Muto Y, Matsumoto K, Nakamura T: Direct evidence that hepatocyte growth factor is a hepatotropic factor for liver regeneration and has a potent antihepatitis effect in vivo. Hepatology 1992;16:1227-1235.
19. Fujiwara K, Nagoshi S, Ohno A, Hirata K, Ohta Y, Mochida S, Tomiya T, Higashio, K, Kurokawa K: Stimulation of liver growth by exogenous human hepatocyte growth factor in normal and partially hepatectomized rats. Hepatology 1993;18:1443-1449.
20. Webber EM, Godowski PJ, Fausto N: In vivo response of hepatocytes to growth factors requires an initial priming stimulus. Hepatology 1994;19:489-497.
21. Mead JE, Fausto N: Transforming growth factor alpha may be a physiological regulator of liver regeneration by means of an autocrine mechanism. Proc Natl Acad Sci USA 1989;86:1558-1562.
22. Zarnegar R, DeFrances MC, Kost DP, Lindroos P, Michalopoulos G: Expression of hepatocyte growth factor mRNA in regenerating rat liver after partial hepatectomy. Biochem Biophys Res Commun 1991;177:559-565.
23. Webber EM, FitzGerald MJ, Brown PI, Bartlett MH, Fausto N: Transforming growth factor-alpha expression during liver regeneration after partial hepatectomy and toxic injury, and potential interactions between transforming growth factor-alpha and hepatocyte growth factor. Hepatology 1993;18:1422-1431.
24. Tomiya T, Ogata I, Fujiwara K: Transforming growth factor alpha levels in liver and blood correlate better than hepatocyte growth factor with hepatocyte proliferation during liver regeneration. Am J Pathol 1998;153:955-961.
25. Tomiya T, Tani M, Yamada S, Hayashi S, Umeda N, Fujiwara K: Serum hepatocyte growth factor levels in hepatectomized and nonhepatectomized surgical patients. Gastroenterology 1992;103:1621-1624.
26. Tomiya T, Nagoshi S, Fujiwara K: Significance of serum human hepatocyte growth factor levels in patients with hepatic failure. Hepatology 1992;15:1-4.
27. Tomiya T, Fujiwara K: Serum levels of transforming growth factor-alpha in patients after partial hepatectomy as determined with an enzyme-linked immunosorbent assay. Hepatology 1993;18:304-308.
28. Tomiya T, Hayashi S, Yanase M, Umeda N, Tani M, Yamada S, Masaki N, Ogata I, Fujiwara K: Serum transforming growth factor alpha level can be a parameter for evaluating liver regeneration after partial hepatectomy in patients with liver cancer. Semin Oncol 1997;24:14-17.
29. Tomiya T, Fujiwara K: Liver regeneration in fulminant hepatitis as evaluated by serum transforming growth factor alpha levels. Hepatology 1996;23:253-257.
30. Seglen PO: Preparation of isolated rat liver cells. Methods Cell Biol 1976;13:29-83.
31. Kavgaci H, Ozdemir F, Ovali E, Yavuz A, Yavuz M, Aydin F: Effect of the farnesyl transferase inhibitor L-744,832 on the colon cancer cell line DLD-1 and its combined use with radiation and 5-FU. Chemotherapy 2005;51:319-323.
32. Shima N, Nagao M, Ogaki F, Tsuda E, Murakami A, Higashio K: Tumor cytotoxic factor/hepatocyte growth factor from human fibroblasts: cloning of its cDNA, purification and characterization of recombinant protein. Biochem Biophys Res Commun 1991;180:1151-1158.
33. Rothschild MA, Oratz M, Schreiber SS: Serum albumin. Hepatology 1988;8:385-401.
34. Parent JB, Bauer HC, Olden K: Three secretory rates in human hepatoma cells. Biochim Biophys Acta 1985;846:44-50.
35. Guillen MI, Gomez-Lechon MJ, Nakamura T, Castell JV: The hepatocyte growth factor regulates the synthesis of acute-phase proteins in human hepatocytes: divergent effect on interleukin-6-stimulated genes. Hepatology 1996;23:1345-1352.
36. Sugiyama K, Emori T, Nagase S: Synthesis and secretion of plasma proteins by isolated hepatocytes of analbuminemic rats. J Biochem 1982;92:775-779.
37. Fuller GM, Zhang Z: Transcriptional control mechanism of fibrinogen gene expression. Ann N Y Acad Sci 2001;936:469-479.
38. Chung J, Kuo CJ, Crabtree GR, Blenis J: Rapamycin-FKBP specifically blocks growth-dependent activation of and signaling by the 70 kd S6 protein kinases. Cell 1992;69:1227-1236.
39. Proud CG: Regulation of mammalian translation factors by nutrients. Eur J Biochem 2002;269:5338-5349.
40. Kimball SR, Jefferson LS: Regulation of global and specific mRNA translation by oral administration of branched-chain amino acids. Biochem Biophys Res Commun 2004;313:423-427.
41. Yoshizawa F: Regulation of protein synthesis by branched-chain amino acids in vivo. Biochem Biophys Res Commun 2004;313:417-422.
42. Sonenberg N, Gingras AC: The mRNA 5′ cap-binding protein eIF4E and control of cell growth. Curr Opin Cell Biol 1998;10:268-275.
43. Ui M, Okada T, Hazeki K, Hazeki O: Wortmannin as a unique probe for an intracellular signalling protein, phosphoinositide 3-kinase. Trends Biochem Sci 1995;20:303-307.